VERTEX PHARMACEUTICALS INCORPORATED (VRTX)
Currency USD
Company Overview
Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which are collectively approved to treat the people with CF in North America, Europe and Australia. Trikafta, Vertex's triple combination regimen, was approved by the FDA for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. While CF remains the main area of focus, Vertex is also developing treatments for sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency and muscular dystrophies. Pimodivir/VX-787, for the treatment of influenza, was out-licensed to Janssen while oncology candidates VX-970, VX-984 and VX-803 were divested to Merck KGaA.
Contact Details
- Address
- 50 NORTHERN AVENUE
- City
- BOSTON
- State
- MA
- Country
- USA
- Zip Code
- 02210
- Phone Number
- 617-341-6100
- Website
- -
Financial Highlights
-
Day Range
The price range a stock has traded at during the most recent trading period.
-
--
-
5 Day Range
The price range a stock has traded at during the previous 5 days.
-
--
-
3 Month Range
The price range a stock has traded at during the previous 3 months.
-
--
-
52 Week Range
The price range a stock has traded at during the previous 52 weeks.
-
--
-
Previous Close
The closing price of a stock from the previous day.
-
-
-
Open
The price of the stock at the start of today’s market opening.
-
-
-
Bid
The amount of money a trader is willing to pay per share for a given stock.
-
x-
-
Ask
The amount of money a seller wants per share of a given stock.
-
x-
-
Volume
The number of shares traded in a given period. This number illustrates the active interest in the stock at any time.
-
-
-
Avg. Volume
The average number of shares traded in a given day.
-
-
-
Dividend Yield
A company's annual dividend expressed as a percentage of its current stock price.
-
-
-
Recent Dividend
The value a shareholder receives from a company they are invested in for holding their shares.
-
-
-
Beta
A measurement of the stock’s volatility in comparison to the market as a whole.
-
-
Shareholding
-
Shares Outstanding
Number of shares currently held by investors, including restricted shares owned by the company's officers and insiders.
-
-
-
Insider Shareholders
The percentage of shares owned by any officer or board director of the company, including their related or affiliated individuals, families, entities and trusts.
-
-
-
Institutional Shareholders
The percentage of shares owned by an institution such as a mutual fund, bank or insurance company.
-
-
-
Market Cap
The market value of a company’s outstanding shares. It is used as a measurement tool to determine how large a company is.
-
-
-
Revenue TTM
The amount of money a company has made for the trailing twelve-month period.
-
-
-
Net Income TTM
A measurement of how much profit they are retaining for the trailing twelve-month period.
-
-
-
P/E Ratio
The Price to Earnings (P/E) ratio, is calculated by dividing the stock's most recent share price by the sum of the diluted earnings per share.
-
-
-
EPS TTM
Earnings Per Share (EPS) TTM is a company's profit for the trailing twelve-month period divided by its number of common outstanding shares.
-
-
-
1 Year Return
A measurement of how much the stock has increased or decreased in the last year.
-
-
There is no stock data currently available for this time period, please select another option.
Please wait, gathering market data...